Korean Market
OWNR
Celltrion
★

Celltrion Executive Gil Seong-min Acquires 249 Free Shares … No Change in Ownership Ratio

 
OWNR
Celltrion
★

Celltrion Non-Registered Executive Gang Seong-hwan Increases Stake via Free Share Allotment Ownership Ratio Unchanged at 0.01%

 
OWNR
Celltrion
★

Celltrion Non-Registered Executive Gu Yun-mo Acquires 843 Free Shares, Ownership Increases to 17,703 Shares... No Impact on Shareholder Value

 
OWNR
Celltrion
★

Celltrion Senior Vice President Kwon Gi-seong Increases Shareholding by 1,570 Shares via Free Stock Grant

 
OWNR
Celltrion
★

Celltrion Non-Registered Executive Gwon Byeong-o Increases Stake by 101 Shares via Free Share Acquisition

 
OWNR
Celltrion
★

Celltrion Executive Kang Seok-hwan Reports Minor Increase in Share Ownership via Free Shares, No Impact on Capital Structure

 
OWNR
Celltrion
★

Celltrion Non-Registered Executive Kang Kyeong-doo Increases Holdings to 1,890 Shares via Free Stock Acquisition of 90 Shares

 
EXCH
Celltrion
★

Celltrion Reports Preliminary Q2 2026 Consolidated Revenue of KRW 1.3 Trillion and Operating Profit of KRW 430 Billion, Up 35% and 77% YoY Respectively

 
OWNR
Celltrion
★

Celltrion Holdings Slightly Increases Stake in Celltrion to 33.07% via Stock Dividend and Open Market Purchases, with Pledge Loan Renewals

 
OTHR
Celltrion
★

Celltrion Completes Treasury Stock Acquisition of 586,927 Shares Worth 99.9 Billion Won Slightly Positive for Shareholder Value

 
OWNR
Celltrion
★

Celltrion Holdings Increases Stake in Celltrion to 25.84% Through Stock Dividend and Market Purchases

 
EXCH
Celltrion
★

Celltrion Files Marketing Authorization Application in Korea for Cosentyx Biosimilar CT-P55 Based on Positive Phase 1 Results

 
EXCH
Celltrion
★

Celltrion's CT-P13 SC Phase 3 Part 1 Approval Expires in Pediatric UC Due to Strategic Shift, Signaling Potential Pipeline Delay

 
EXCH
Celltrion
★

Celltrion's CT-P13 SC Pediatric Crohn's Phase 3 Part 1 Approval Expires, Trial Plan to Be Revised Due to Development Strategy Change

 
EXCH
Celltrion
★

Celltrion Amends Corporate Governance Report Highlighting Strong Board Independence and Shareholder Return Policies